- Home
- SCHL vs PRME Comparison
SCHL vs PRME Comparison
Compare SCHL & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCHL
- PRME
- Stock Information
- Founded
- SCHL 1920
- PRME 2019
- Country
- SCHL United States
- PRME United States
- Employees
- SCHL N/A
- PRME N/A
- Industry
- SCHL Books
- PRME Medicinal Chemicals and Botanical Products
- Sector
- SCHL Consumer Discretionary
- PRME Health Care
- Exchange
- SCHL Nasdaq
- PRME Nasdaq
- Market Cap
- SCHL 615.7M
- PRME 624.0M
- IPO Year
- SCHL 1987
- PRME 2022
- Fundamental
- Price
- SCHL $25.41
- PRME $3.55
- Analyst Decision
- SCHL
- PRME Buy
- Analyst Count
- SCHL 0
- PRME 6
- Target Price
- SCHL N/A
- PRME $8.88
- AVG Volume (30 Days)
- SCHL 292.6K
- PRME 4.0M
- Earning Date
- SCHL 09-25-2025
- PRME 08-07-2025
- Dividend Yield
- SCHL 3.15%
- PRME N/A
- EPS Growth
- SCHL N/A
- PRME N/A
- EPS
- SCHL N/A
- PRME N/A
- Revenue
- SCHL $1,625,500,000.00
- PRME $4,961,000.00
- Revenue This Year
- SCHL $4.15
- PRME $179.58
- Revenue Next Year
- SCHL $3.96
- PRME N/A
- P/E Ratio
- SCHL N/A
- PRME N/A
- Revenue Growth
- SCHL 2.25
- PRME 739.42
- 52 Week Low
- SCHL $15.77
- PRME $1.11
- 52 Week High
- SCHL $34.18
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- SCHL 57.31
- PRME 48.57
- Support Level
- SCHL $24.53
- PRME $3.09
- Resistance Level
- SCHL $26.29
- PRME $3.88
- Average True Range (ATR)
- SCHL 0.79
- PRME 0.31
- MACD
- SCHL -0.19
- PRME -0.09
- Stochastic Oscillator
- SCHL 55.65
- PRME 32.96
About SCHL Scholastic Corporation
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.